Central serous chorioretinopathy treatment with a systemic PDE5 and PDE6 inhibitor (sildenafil)

Central serous chorioretinopathy treatment with a systemic PDE5 and PDE6 inhibitor (sildenafil)

Purpose: Examine the use of systemic phosphodiesterase inhibition (sildenafil) to clear central serous chorioretinopathy (CSCR). Observations: In a long-standing CSCR patient, sildenafil produced a rapid resolution. When discontinued (dechallenge) the CSCR returned. When rechallenged, the CSCR again...

Full description

Bibliographic Details
Main Authors: D. Jackson Coleman, Winston Lee, Suzanne Daly, Mark P. Breazzano, Janet Sparrow, Stephen H. Tsang
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
PDE5/6 inhibitor
Sildenafil
Central serous chorioretinopathy
Online Access:http://www.sciencedirect.com/science/article/pii/S2451993620303133

Internet

http://www.sciencedirect.com/science/article/pii/S2451993620303133

Similar Items